Skip to main content
G
Brand Partner

GlycanAge

GlycanAge is a biotechnology company specializing in glycan-based biological-age testing. Its flagship at-home test analyzes IgG glycan patterns to provide insights into biological aging and inflammation-related biomarkers. The company serves consumers, healthcare professionals, and longevity practitioners interested in personalized health and preventive care.

Visit Website
35,140+Total Reach
0 videos

About GlycanAge

GlycanAge Ltd is a biotechnology company headquartered in Newcastle upon Tyne, England, specializing in glycan science and biological-age testing. The company applies research into glycans—complex sugar molecules involved in biological processes—to develop tools that help people understand aspects of their biological aging and health.

Its flagship product, the GlycanAge test, is an at-home testing service that analyzes IgG glycan patterns to generate a biological-age assessment. The company positions this information as an additional way for consumers and healthcare professionals to explore aging-related biomarkers and monitor changes over time.

GlycanAge’s business combines scientific research, testing technology, a digital platform, and commercial distribution. Its customer groups include individual consumers, longevity clinics, preventive-health practitioners, and healthcare providers interested in personalized health assessments. The company also develops professional relationships and partnerships intended to expand access to its testing technology.

The business is built on research led by Professor Gordan Lauc, a glycobiology researcher, and commercialized by co-founder and CEO Nikolina Lauc. Technology and product development are supported by CTO Filip Lauc and the wider leadership team.

For B2B growth, GlycanAge may be a relevant prospect for healthcare-provider lead generation, clinic and practitioner prospecting, strategic partnership research, and targeted LinkedIn or email outreach. Potential opportunities include identifying longevity clinics, preventive-health providers, and diagnostic or wellness organizations that may benefit from its testing services. Its current external marketing requirements and agency relationships have not been publicly verified.

GlycanAge’s test provides a biomarker-based assessment and should not be treated as a standalone diagnosis or a definitive measure of overall health or lifespan. The company’s scientific and clinical claims should be evaluated against the underlying research and intended use of the test.